Clinical trials: EV71
EV71 Vaccine
Clinical Trial for Batch Consistency of EV71 Vaccine
This trial is designed as a single-center, randomized, double-blind study. A total of 720 infants aged 6 to 35 months are selected (with 240 subjects in each age group: 6-11 months, 12-23 months, and 24-35 months).
- Trial name
- NCT07026500
- Testing
- EV71 Vaccine
- Where
- China
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- Sinovac Biotech Co., Ltd